Biortus one-stop service supports the research and development of new drugs for China Innovation Center of Roche (CICoR), published in Nature Communications

On April 11, 2024, Nature Communications published online an article of China Innovation Center of Roche (CICoR) in collaboration with Biortus, introducing the cryo-EM structure of the dimeric human parainfluenza virus type 3 (hPIV3) L-P complex.

2024

/

06

Biortus Announces Strategic Collaboration with Schrödinger

Today, Biortus Biosciences Co. Ltd. (“Biortus”) announced a multi-year partnership with Schrodinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered

2024

/

03

Go BIG! - Purification and Structural Determination of RyR1, 2.3MDa membrane protein

With our state-of-the-art CryoEM facility and gene-to-structure pipeline, Biortus’s experienced team has solved a 2.8 Å CryoEM structure of RyR1, the largest known ion channel at 2.3 MDa.

2023

/

02

Biortus Delivering hERG Protein and Cryo-EM Structures

As part of the drug safety assessment practice, ion channels are one of the key family proteins under tight scrutiny with almost every drug candidate. Unfortunately, as of now the effect of drug candi

2022

/

04

Biortus Delivering ABCB10 Protein and Cryo-EM Structures

A member of ATP-binding cassette (ABC) transporter family located in the inner membrane of mitochondria, ABCB10 in the liver functions as a transporter of liver biliverdin, the reduction product of bilirubin (Fig. 1).

2022

/

04

Installed Krios G4 Boosts Productivity at Biortus CryoEM Center

Reporting from Wuxi, the long anticipated Titan Krios G4, the first of its kind in China, is now installed and operational at the Biortus CryoEM Center.

2021

/

05

< 123 >

MESSAGE

Submit
%{tishi_zhanwei}%